Moderna
MRNA
#1188
Rank
โ‚น1.832 T
Marketcap
โ‚น4,620
Share price
-3.35%
Change (1 day)
97.03%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

Earnings for Moderna (MRNA)

Earnings in 2025 (TTM): -โ‚น239.96 Billion

According to Moderna 's latest financial reports the company's current earnings are โ‚น1.92 Billion. , an increase over its 2024 earnings that were of -โ‚น337.6 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Moderna from 2018 to 2025

Annual earnings

Year Earnings Change
2025 -โ‚น259.86 Billion-23.03%
2024 -โ‚น337.6 Billion-8.22%
2023 -โ‚น367.84 Billion-140.65%
2022 โ‚น904.88 B-27.81%
2021 โ‚น1.253 T-1911.15%
2020 -โ‚น69.21 Billion44.7%
2019 -โ‚น47.83 Billion28.63%
2018 -โ‚น37.19 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
โ‚น3.161 T-1,316.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
โ‚น1.540 T-692.89%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Merck
MRK
โ‚น2.112 T-913.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Regulus Therapeutics
RGLS
-โ‚น4.47 Billion-98.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
-โ‚น11.09 Billion-95.73%๐Ÿ‡บ๐Ÿ‡ธ USA
Athersys
ATHX
-โ‚น3.94 Billion-98.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
โ‚น54.24 B-120.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Arrowhead Pharmaceuticals
ARWR
โ‚น32.51 B-112.51%๐Ÿ‡บ๐Ÿ‡ธ USA